Researchers have distinguished the nerve cells in the brain that control the beneficial effects of GLP-1R agonists – such as ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Weight-loss drugs cannot be a short-term solution and GPs will need to engage with obesity management as the medicines are ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t ...

“[The medication] is not for casual weight loss or for people with medical histories that preclude its use,” says Dr. Gould. This includes individuals allergic to semaglutide or other ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

A doctor has warned of the 'multitude of factors' which could risk any long-term results once someone stops taking Ozempic.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

Some say that Ozempic can lead to surprise pregnancies, referred to as "Ozempic babies," by increasing fertility. Learn what ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...